Shares of Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) have received a consensus recommendation of “Buy” from the fifteen ...

Guardant Health (GH) saw its shares surge in the last session with trading volume being higher than average. The latest trend ...

Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company focusing on developing innovative immunotherapies for patients with cancer and other incurable diseases, has announced positive data from its ...

Which biotechs are most likely to be acquired near-term? We asked Seeking Alpha analysts Edmund Ingham and Terry Chrisomalis for their thoughts on the topic. Read more here.

Ahead of the 2025 J.P. Morgan Healthcare Conference scheduled to take place in a few days, Oppenheimer named five potential buyout candidates in biotech on Friday, naming obesity drug developer Viking ...

Oppenheimer laid out five “aspirational” potential takeover targets in biotech heading into the annual JPMorgan Health Care Conference. “We ...

Below is a chart showing TTI's trailing twelve month trading history, with the $5 strike highlighted in orange: And Arcellx Inc (Symbol: ACLX) options are showing a volume of 3,325 contracts thus ...

There are no important events for this country at this time. Select "All" to see top events in other countries or view all events.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Below is Validea's guru fundamental report for ARCELLX INC (ACLX). Of the 22 guru strategies we follow, ACLX rates highest using our P/B Growth Investor model based on the published strategy of ...

Buy ACLX near 82.72 target 98.67 stop loss @ 82.48 Details The technical summary data tells us to buy ACLX near 82.72 with an upside target of 98.67. This data also tells us to set a stop loss @ 82.48 ...